Simona Skerjanec
Chairman
Immunic, Inc. (IMUX)Board Member
Immunic, Inc. (IMUX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Simona Skerjanec
Simona Skerjanec is recorded as Chairman and Board Member at Immunic, Inc. (IMUX). Immunic, Inc. reported in an 8-K filed February 13, 2026 that Simona Skerjanec was appointed Interim Chairperson of the Board of Directors. Immunic, Inc. reported in an 8-K filed February 13, 2026 that Simona Skerjanec was appointed Interim Chairperson of the Board, effective February 12, 2026.
“Simona Skerjanec, former SVP, Global Head of Neuroscience and Rare Diseases at Roche, who joined Immunic's Board of Directors in July 2024, has been elevated to Interim Chairperson of the Board of Directors.”
“On February 12, 2026, the Board, following the recommendation of the Committee, appointed Simona Skerjanec to serve as Interim Chairperson of the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-02-12–present
-
Current
2024-07-22–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Immunic, Inc.
Other people whose current roles at this company are on record from its filings.
- Dr. Daniel Vitt CEO
- Duane D. Nash CEO
- Duane Nash CEO
- Erik Lundgren CEO, Board Member
- Russell J. Cox CEO
- Michael W. Bonney Chairman
- Glenn Whaley CFO
- Jason Tardio COO
- Inderpal Singh General Counsel
- Barclay Phillips Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.